Free Trial

Compugen (CGEN) Short Interest Ratio & Short Volume

Compugen logo
$2.13 +0.01 (+0.47%)
Closing price 04:00 PM Eastern
Extended Trading
$2.12 0.00 (-0.23%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compugen Short Interest Overview

As of September 30, 2026, Compugen (CGEN) had a short interest of 2.35 million shares sold short, representing 2.75% of the public float. This marks a -0.54% decrease in short interest since the prior report. The short interest ratio (days to cover) is 16.1, meaning it would take 16.1 days of the average trading volume of 172,882 shares to cover all short positions.

Current Short Interest
2,354,274 shares
Previous Short Interest
2,366,980 shares
Change Vs. Previous Month
-0.54%
Dollar Volume Sold Short
$5.60 million
Short Interest Ratio
16.1 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
94,550,000 shares
Short Percent of Float
2.75%
Today's Trading Volume
123,364 shares
Average Trading Volume
172,882 shares
Today's Volume Vs. Average
71%
Short Selling Compugen?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Compugen and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

CGEN Short Interest Over Time

CGEN Days to Cover Over Time

CGEN Percentage of Float Shorted Over Time

Compugen Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/20262,354,274 shares $5.60 million -0.5%2.8%16.1 $2.38
9/15/20262,366,980 shares $5.70 million +0.8%2.8%12.01 $2.41
8/31/20262,349,292 shares $6.01 million -22.5%2.7%6.11 $2.56
8/14/20263,032,032 shares $7.31 million +7.7%3.5%10.01 $2.41
7/31/20262,814,877 shares $6.61 million -7.0%3.3%13.02 $2.35
7/15/20263,027,148 shares $7.14 million +8.2%3.5%11.17 $2.36
6/30/20262,797,911 shares $5.99 million -2.5%3.3%9.98 $2.14
6/15/20262,869,956 shares $5.80 million +17.2%3.4%5.71 $2.02
5/29/20262,449,496 shares $6.44 million +44.8%2.9%3.93 $2.63
5/15/20261,691,130 shares $4.65 million +18.9%2.0%3.78 $2.75
4/30/20261,422,380 shares $3.78 million +26.7%1.7%2.39 $2.66
4/15/20261,122,600 shares $3.24 million +19.9%1.3%2.27 $2.89
3/31/2026936,019 shares $1.99 million -6.5%1.1%4.65 $2.13
3/13/20261,000,744 shares $2.24 million -6.0%1.2%2.04 $2.24
2/27/20261,064,062 shares $1.93 million +18.5%1.2%6.47 $1.81
2/13/2026897,924 shares $1.48 million -8.3%1.0%3.88 $1.65
1/30/2026979,325 shares $1.80 million -14.0%1.1%2.79 $1.84
1/15/20261,138,999 shares $2.40 million -4.6%1.3%1.42 $2.11
12/31/20251,194,354 shares $1.83 million +26.8%1.4%2.52 $1.53
12/15/2025941,812 shares $1.41 million +3.6%1.1%3 $1.50
11/28/2025909,256 shares $1.42 million -7.3%1.1%3.29 $1.56
11/14/2025981,261 shares $1.61 million +2.8%1.2%3.43 $1.64
10/31/2025954,194 shares $1.69 million -2.3%1.2%2.26 $1.77
10/15/2025976,500 shares $2.01 million +7.5%1.2%2.7 $2.06
9/30/2025908,400 shares $1.34 million -3.8%N/A3.2 $1.47
9/15/2025943,800 shares $1.30 million +0.2%N/A3.9 $1.38
8/31/2025941,700 shares $1.33 million +4.3%1.2%4.5 $1.41
8/15/2025903,300 shares $1.29 million -32.6%N/A3.9 $1.43
7/31/20251,340,000 shares $1.94 million -2.2%1.7%5.7 $1.45
7/15/20251,370,000 shares $2.16 million -7.4%N/A6 $1.58
6/30/20251,480,000 shares $2.63 million +1.4%1.8%6.4 $1.78
6/15/20251,460,000 shares $2.39 million -0.7%1.8%6.1 $1.64
5/31/20251,470,000 shares $2.19 million -4.6%1.8%5.6 $1.49
5/15/20251,540,000 shares $2.11 million -10.5%1.9%5.8 $1.37
4/30/20251,720,000 shares $2.75 million -6.5%N/A5.1 $1.60
4/15/20251,840,000 shares $2.54 million -5.2%2.3%4.6 $1.38
3/31/20251,940,000 shares $2.83 million +4.3%2.4%3.1 $1.46
3/15/20251,860,000 shares $3.07 million +12.1%2.3%2.9 $1.65
2/28/20251,660,000 shares $3.19 million +5.1%2.1%2.4 $1.92
2/15/20251,580,000 shares $3.51 million +12.1%2.0%2.3 $2.22
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
1/31/20251,410,000 shares $3.29 million -1.4%N/A2 $2.33
1/15/20251,430,000 shares $2.87 million +12.6%N/A2.4 $2.01
12/31/20241,270,000 shares $1.94 million -3.8%N/A3.4 $1.53
12/15/20241,320,000 shares $2.13 million -0.8%N/A4.1 $1.61
11/30/20241,330,000 shares $2.11 million +0.8%N/A4.8 $1.59
11/15/20241,320,000 shares $1.86 million +3.9%N/A5.5 $1.41
10/31/20241,270,000 shares $2.03 million -18.1%N/A5.6 $1.60
10/15/20241,550,000 shares $2.53 million -17.1%N/A6.7 $1.63
9/30/20241,870,000 shares $3.38 million -0.5%N/A7.6 $1.81
9/15/20241,880,000 shares $3.70 million +15.3%N/A7.3 $1.97
8/31/20241,630,000 shares $3.42 million -5.8%N/A6.1 $2.10
8/15/20241,730,000 shares $3.13 million +3.0%N/A6 $1.81
7/31/20241,680,000 shares $2.97 million -4.0%N/A5 $1.77
7/15/20241,750,000 shares $3.34 million -0.6%N/A5.1 $1.91
6/30/20241,760,000 shares $2.96 million +0.6%N/A5.1 $1.68
6/15/20241,750,000 shares $3.62 million -3.3%N/A5.1 $2.07
5/31/20241,810,000 shares $3.93 million +4.6%N/A5 $2.17
5/15/20241,730,000 shares $3.82 million -11.3%N/A3.3 $2.21
4/30/20241,950,000 shares $3.76 million No ChangeN/A4 $1.93
4/15/20241,950,000 shares $3.82 million -6.7%N/A3.4 $1.96
3/31/20242,090,000 shares $5.39 million +11.8%N/A3.2 $2.58
3/15/20241,870,000 shares $5.11 million +2.2%N/A2.1 $2.73
2/29/20241,830,000 shares $4.72 million -9.4%N/A0.7 $2.58
2/15/20242,020,000 shares $4.69 million +23.9%2.4%0.8 $2.32
1/31/20241,630,000 shares $3.93 million +1.9%2.0%0.6 $2.41
1/15/20241,600,000 shares $2.88 million -24.5%1.9%0.6 $1.80
12/31/20232,120,000 shares $4.20 million +45.2%2.5%0.9 $1.98
12/15/20231,460,000 shares $1.10 million -3.3%1.8%0.6 $0.76
11/30/20231,510,000 shares $1.00 million +11.9%1.8%8.3 $0.66
11/15/20231,350,000 shares $832.82 thousand -10.6%1.6%7.7 $0.62
10/31/20231,510,000 shares $1.15 million No Change1.8%6.2 $0.76
10/15/20231,510,000 shares $1.27 million -4.4%1.8%5.9 $0.84
9/30/20231,580,000 shares $1.47 million -3.7%1.9%5.5 $0.93
9/15/20231,640,000 shares $1.75 million -6.3%2.0%5.5 $1.07
8/31/20231,750,000 shares $2.00 million +12.2%2.1%4.6 $1.14
8/15/20231,560,000 shares $1.62 million -3.1%1.9%2.9 $1.04
7/31/20231,610,000 shares $1.87 million +3.9%2.0%3.3 $1.16
7/15/20231,550,000 shares $1.94 million -3.1%N/A3.3 $1.25
6/30/20231,600,000 shares $1.82 million +4.6%N/A3.5 $1.14
6/15/20231,530,000 shares $2.10 million -9.5%N/A3.4 $1.37
5/31/20231,690,000 shares $1.72 million -7.1%2.1%4.2 $1.02
5/15/20231,820,000 shares $1.48 million +2.8%2.2%6.6 $0.81
4/30/20231,770,000 shares $1.04 million -7.8%2.2%6.5 $0.59
4/15/20231,920,000 shares $1.22 million +1.6%2.4%5.4 $0.63
3/31/20231,890,000 shares $1.33 million -5.5%2.3%4.4 $0.70
3/15/20232,000,000 shares $1.51 million -4.3%2.4%4 $0.76
2/28/20232,090,000 shares $1.65 million +14.2%2.6%3.6 $0.79
2/15/20231,830,000 shares $1.47 million -2.1%2.2%2.9 $0.81
1/31/20231,870,000 shares $1.62 million -7.4%2.3%2.8 $0.87
1/15/20232,020,000 shares $2.14 million +2.5%2.5%2.8 $1.06
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
12/30/20221,970,000 shares $1.41 million -24.2%2.4%2.3 $0.72
12/15/20222,600,000 shares $2.17 million -2.3%3.2%3 $0.84
11/30/20222,660,000 shares $3.19 million -0.4%3.3%2.7 $1.20
11/15/20222,670,000 shares $2.31 million -1.1%3.3%2.6 $0.87
10/31/20222,700,000 shares $2.57 million -4.6%3.3%2.1 $0.95
10/15/20222,830,000 shares $2.16 million +28.6%3.5%2.2 $0.76
9/30/20222,200,000 shares $1.45 million +3.8%2.7%1.9 $0.66
9/15/20222,120,000 shares $2.23 million -22.3%2.6%1.9 $1.05
8/31/20222,730,000 shares $3.19 million -13.1%3.4%2.4 $1.17
8/15/20223,140,000 shares $4.62 million -6.0%3.9%3 $1.47
7/31/20223,340,000 shares $5.38 million -5.4%6.1%3.7 $1.61
7/15/20223,530,000 shares $6.60 million +5.1%6.5%4 $1.87
6/30/20223,360,000 shares $6.22 million -7.7%6.1%3.8 $1.85
6/15/20223,640,000 shares $6.08 million -11.7%6.7%4 $1.67
5/31/20224,120,000 shares $7.62 million -16.4%5.5%4.5 $1.85
5/15/20224,930,000 shares $9.51 million +11.3%6.6%5.3 $1.93
4/30/20224,430,000 shares $10.54 million +1.4%5.9%4.9 $2.38
4/15/20224,370,000 shares $11.41 million +4.8%5.8%4.6 $2.61
3/31/20224,170,000 shares $13.43 million -4.8%5.1%4.3 $3.22
3/15/20224,380,000 shares $12.79 million -28.6%5.4%4.4 $2.92
2/28/20226,130,000 shares $18.94 million +7.7%7.5%5.7 $3.09
2/15/20225,690,000 shares $18.32 million -1.7%7.2%5.4 $3.22
1/31/20225,790,000 shares $20.55 million +8.4%7.3%4.2 $3.55
1/15/20225,340,000 shares $20.77 million +3.7%6.8%4 $3.89
12/31/20215,150,000 shares $22.15 million -3.6%6.5%3.9 $4.30
12/15/20215,340,000 shares $22.75 million -10.7%6.8%4.1 $4.26
11/30/20215,980,000 shares $26.43 million +24.6%7.6%5.1 $4.42
11/15/20214,800,000 shares $26.16 million -11.3%6.1%4.3 $5.45
10/29/20215,410,000 shares $35.11 million -4.1%N/A7.5 $6.49
10/15/20215,640,000 shares $35.87 million -11.9%N/A8 $6.36

CGEN Short Interest - Frequently Asked Questions

Short interest is the volume of Compugen shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 2,354,274 shares of CGEN short. 2.75% of Compugen's shares are currently sold short. Learn More on Compugen's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEN shares currently have a short interest ratio of 16.1. Learn More on Compugen's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.75% of Compugen's floating shares are currently sold short.

Compugen saw a drop in short interest in September. As of September 30th, there was short interest totaling 2,354,274 shares, a drop of 0.5% from the previous total of 2,366,980 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.75% of Compugen's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Compugen: Sana Biotechnology, Inc. (17.34%), Geron Corporation (11.70%), Annexon, Inc. (18.83%), Lexicon Pharmaceuticals, Inc. (6.75%), Candel Therapeutics, Inc. (19.82%), Design Therapeutics, Inc. (12.75%), Solid Biosciences Inc. (12.19%), ArriVent BioPharma, Inc. (18.75%), Sensei Biotherapeutics, Inc. (8.60%), Avalo Therapeutics, Inc. (22.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling CGEN is an investing strategy that aims to generate trading profit from Compugen as its price is falling. CGEN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Compugen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEN, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CGEN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:CGEN is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners